Kit Man Wong

1.7k total citations
32 papers, 793 citations indexed

About

Kit Man Wong is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kit Man Wong has authored 32 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Kit Man Wong's work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Kit Man Wong is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Kit Man Wong collaborates with scholars based in United States, Canada and Hong Kong. Kit Man Wong's co-authors include William Proctor Harris, Sabine Eckhardt, Anna Capasso, Thomas J. Hudson, John D. McPherson, Andrew L. Coveler, Sunil R. Hingorani, Ho Lam Tang, Kan Liu and Denise J. Montell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Kit Man Wong

31 papers receiving 779 citations

Peers

Countries citing papers authored by Kit Man Wong

Since Specialization

Citations

This map shows the geographic impact of Kit Man Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kit Man Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kit Man Wong more than expected).

Fields of papers citing papers by Kit Man Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kit Man Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kit Man Wong. The network helps show where Kit Man Wong may publish in the future.

Co-authorship network of co-authors of Kit Man Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Kit Man Wong. A scholar is included among the top collaborators of Kit Man Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kit Man Wong. Kit Man Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I/Ib study of afatinib with capecitabine in patients with refractory solid tumors and pancreaticobiliary cancers. 2025 ·Journal of Clinical Oncology ·Gentry Teng King, Kelsey K. Baker, Andrew L. Coveler, Rachael A. Safyan, Kit Man Wong, Veena Shankaran, David B. Zhen, (unknown), (unknown), (unknown), Greg Andrew Durm, Mary W. Redman, Colin C. Pritchard, Safi Shahda, E. Gabriela Chiorean	1
2	Assessing the reliability of the FricTest^® 4.0 for diagnosing symptomatic dermographism 2024 ·Clinical and Translational Allergy ·(unknown), Martin Metz, Melba Muñoz, Kit Man Wong, (unknown), Rui Zhao, Marcus Maurer, Vasiliki Zampeli, Markus Magerl	1
3	The Treatment Landscape of Advanced Hepatocellular Carcinoma 2022 ·Current Oncology Reports ·Kit Man Wong, (unknown), William Proctor Harris	23
4	PF-06939999, a potent and selective PRMT5 inhibitor, in patients with advanced or metastatic solid tumors: A phase 1 dose escalation study. 2021 ·Journal of Clinical Oncology ·Jordi Rodón, Cesar A. Perez, Kit Man Wong, Michael L. Maitland, Frank Tsai, Jordan Berlin, Ken Liao, I‐Ming Wang, (unknown), Ira Jacobs, (unknown), (unknown), Anthony W. Tolcher	26
5	Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor Board 2020 ·Targeted Oncology ·Laura C. Kennedy, Kit Man Wong, Nikhil Kamat, Ali Raza Khaki, Shailender Bhatia, John A. Thompson, Petros Grivas	9
6	Investigating the Impact of Geographic Location on Colorectal Cancer Stage at Diagnosis: A National Study of the SEER Cancer Registry 2019 ·The Journal of Rural Health ·C. Holly A. Andrilla, (unknown), Kit Man Wong, David Evans	28
7	Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers 2018 ·Seminars in Oncology ·William Proctor Harris, Kit Man Wong, Supriya K. Saha, Imane El Dika, Ghassan K. Abou‐Alfa	9
8	Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors 2018 ·Cancer Chemotherapy and Pharmacology ·Colin D. Weekes, Lee S. Rosen, Anna Capasso, Kit Man Wong, Weilan Ye, Maria Anderson, Bruce McCall, Jill Fredrickson, Eric Wakshull, Steve Eppler, (unknown), Rupal Desai, Mahrukh Huseni, Priti S. Hegde, Tony Pourmohamad, Ina Rhee, Alberto Bessudo	15
9	Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20) 2017 ·Current Oncology Reports ·Kit Man Wong, (unknown), Andrew L. Coveler, Sunil R. Hingorani, William Proctor Harris	105
10	Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924) 2016 ·Investigational New Drugs ·Kit Man Wong, (unknown), Heather M. Selby, Aik Choon Tan, Todd M. Pitts, Stacey M. Bagby, Anna Spreafico, (unknown), Stephen J. Blakemore, Peter F. Smith, Alice McDonald, Allison Berger, John J. Tentler, Sabine Eckhardt	16
11	A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non–Small-Cell Lung Cancer 2016 ·Clinical Lung Cancer ·Kit Man Wong, Keyue Ding, Suzanne C. Li, Penelope A. Bradbury, Ming‐Sound Tsao, Sandy D. Der, Frances A. Shepherd, (unknown), Raymond Ng, Lesley Seymour, Natasha B. Leighl	3
12	Validation of a robust PCR-based assay for quantifying fragile X CGG repeats 2016 ·Clinica Chimica Acta ·Yvonne K. Kwok, Kit Man Wong, Ivan F. M. Lo, Grace Kong, (unknown), Shaoping Wu, Stephen T.S. Lam, (unknown), Tak Yeung Leung, Kwong Wai Choy	7
13	Alectinib for the treatment of ALK-positive stage IV non-small celllung cancer 2015 ·Drugs of today ·Kit Man Wong, Sinéad Noonan, Cindy L. O’Bryant, Antonio Jimeno	5
14	The changing landscape of phase I trials in oncology 2015 ·Nature Reviews Clinical Oncology ·Kit Man Wong, Anna Capasso, Sabine Eckhardt	62
15	Nintedanib, a novel triple angiokinase inhibitor for the treatmentof non-small cell lung cancer 2015 ·Drugs of today ·Sinéad Noonan, Kit Man Wong, Antonio Jimeno	6
16	The impact of body mass index on survival in stage 3 and 4 lung cancer. 2013 ·Journal of Clinical Oncology ·Kit Man Wong, Sinéad Cuffe, Linda Coate, Osvaldo Espin‐Garcia, Kevin Boyd, Ronald Feld, Natasha B. Leighl, Frances A. Shepherd, Wei Xu, Geoffrey Liu	3
17	Incidence and Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation 2012 ·Biology of Blood and Marrow Transplantation ·Kit Man Wong, Eshetu G. Atenafu, Dennis Kim, John Kuruvilla, Jeffrey H. Lipton, Hans A. Messner, Vikas Gupta	22
18	Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response 2012 ·Molecular Biology of the Cell ·Ho Lam Tang, Ho Man Tang, (unknown), Shaomin Hu, Shanshan Wang, Kit Man Wong, Chung Wong, (unknown), (unknown), Kan Liu, C. Conover Talbot, (unknown), Denise J. Montell, Ming Chiu Fung	208
19	The novel immunoregulatory molecule FGL2: A potential biomarker for severity of chronic hepatitis C virus infection 2010 ·Journal of Hepatology ·Katharina Foerster, Ahmed Helmy, Yi Zhu, Ramzi Khattar, Oyedele Adeyi, Kit Man Wong, Itay Shalev, David A. Clark, (unknown), E. Jenny Heathcote, M. J. Phillips, David Grant, Eberhard L. Renner, Gary Levy, Nazia Selzner	53
20	The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis # 2008 ·Hepatology ·Itay Shalev, Kit Man Wong, Katharina Foerster, Yi Zhu, Clw Chan, (unknown), Jianhua Zhang, (unknown), Xiao Yang, (unknown), Hao Liu, Nazia Selzner, David A. Clark, Oyedele Adeyi, James M. Phillips, (unknown), David Grant, Ian D. McGilvray, Gary Levy	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact